Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 11 Show results per page	View Search Criteria \| Help With Results


1.		A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				20 to 75				Other				JCOG-0205-MF C000000193, NCT00190515

Last Modified: 9/1/1998


2.		Phase II Study with UFT Plus Leucovorin Calcium for Metastatic Gastric Cancer (Summary Last Modified 09/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								EORTC-16964G

Last Modified: 12/1/1999 First Published: 9/1/1999


3.		Phase II Randomized Study of Oral Fluorouracil-uracil and Leucovorin Calcium Versus Intravenous Fluorouracil and Leucovorin Calcium in Patients with Previously Untreated Advanced Colorectal Cancer (Summary Last Modified 12/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								EORTC-16966C

Last Modified: 12/4/2007 First Published: 3/1/2000


4.		Phase II Study of Fluorouracil-Uracil and Leucovorin Calcium (Orzel) in Elderly Patients With Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				75 and over				NCI				E-1299 NCT00004860, E1299

Last Modified: 8/1/2001 First Published: 5/1/2000


5.		Phase II Study of Fluorouracil-Uracil and Leucovorin Calcium as First Line Therapy in Women With Metastatic Breast Cancer (Summary Last Modified 08/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI, Pharmaceutical / Industry				NU-99B3 BMS-NU-99B3, NU-DRUG-BMS-ORZEL, NCI-G00-1741, NCT00005608


6.		A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients With Metastatic Esophageal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 to 79				Other				BMS-200604 UMCC 0110g, NCT00037089


7.		Study to Evaluate the Efficacy and Safety of FOLFOX-4 Plus Cetuximab Versus UFOX Plus Cetuximab.

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				EMR200025-001 NCT00439517

Last Modified: 4/1/2002


8.		Phase I Pilot Study of Postoperative Oral Fluorouracil-Uracil Plus Leucovorin Calcium Concurrently With Radiotherapy in Patients With Colorectal Cancer (Summary Last Modified 04/2002)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				Pharmaceutical / Industry				MSKCC-96025 BMS-MSKCC-96025, NCI-V96-0942, NCT00002801

Last Modified: 5/10/2007 First Published: 8/1/1999


9.		Phase I Study of Gemcitabine, Fluorouracil-Uracil, and Leucovorin Calcium in Patients With Advanced Refractory Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				WSU-D-1641 WSU-04-28-98-M02-FB, NCI-G99-1526, NCT00003925

Last Modified: 9/1/2001 First Published: 2/1/2001


10.		Phase I Study of Oral Etoposide and Fluorouracil-Uracil Plus Leucovorin Calcium in Patients With Advanced Solid Tumors (Summary Last Modified 09/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over				NCI				PCI-98013 PCI-IRB-990923, NCI-G00-1902, NCT00009815

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute